Introduction to Thymalin 10mg
Thymalin 10mg is a peptide bioregulator originally developed in Russia, derived from the thymus gland, and used in research to explore its potential effects on immune system modulation and overall health.
Mechanism of Action
Thymalin functions by stimulating immune responses, particularly enhancing T-cell activity, which is important for identifying and eliminating pathogens. It also plays a role in regulating inflammatory processes to support balanced immune function. Thymalin’s primary action is to support the restoration and maintenance of natural immune defenses.
Key Research Areas
Preclinical and experimental studies suggest Thymalin may:
Enhance immune system function
Modulate inflammation
Promote tissue repair
Support anti-aging processes
Important Notice
Thymalin 10mg is intended for research use only and is not approved for human consumption or medical treatment. Proper laboratory safety and handling protocols should be observed.
Certificate of Analysis
Property | Description |
Chemical Sequence | H-Pyr-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn-OH |
CAS | 79621-14-0 |
Appearance | White Lyophilized Powder |
Learn More About Thymalin
- “The Use of Thymalin for Immunocorrection and Molecular Aspects of Biological Activity” – This article explores the molecular mechanism of the action of Thymalin and its components. It discusses how Thymalin is used for various diseases associated with immune dysfunction, viral and bacterial infections, regeneration normalization, immunodepression, and the depression of hematogenesis after chemical and radiotherapy
- “Peptide Drug Thymalin Regulates Immune Status in Severe COVID-19 Older Patients” – This article discusses the effectiveness of Thymalin in severe COVID-19 in older patients. It shows that patients administered with Thymalin manifested a more rapid clinical improvement, higher proportions of recovery from lymphopenia, faster normalization of the concentration of C-reactive protein, D-dimer, the number of lymphocytes and NK-cells in the blood, compared to patients who received a standard therapy only
- “Thymalin: Activation of Differentiation of Human Hematopoietic Stem” – This article studies the influence of Thymalin on differentiation of human hematopoietic stem cells (HSC) and expression of CD28 molecule involved in the implementation of antiviral immunity in COVID-19 infection
- “Thymalin as a Potential Alternative in the Treatment of Severe Acute” – This article discusses how Thymalin has been successfully used in clinical practice as an adjunct therapy in the treatment of patients infected with influenza, viral hepatitis B and C, herpes simplex and human immunodeficiency virus (HIV); moreover, several clinical studies demonstrated its beneficial effect in the treatment of severe sepsis and acute respiratory distress syndrome (ARDS)
- “Thymalin Peptide Benefits, Dosage & Side Effects” – This article provides an overview of the benefits of Thymalin, including improved inflammatory response and tissue repair, improved host defense to infection, improved hemopoiesis, blood coagulation and microcirculation, and decreased period of treatment